Welcome to our Evotec Blog.

Hope you will find our articles and resources relevant for your projects and interests.

Our experts are available for any additional information and to assist with your project challenges!

Just contact us.




Improving the translational relevance of preclinical models for pulmonary fibrosis
Vince Russell, 29 January 2018

Preclinical models play a vital role in understanding the potency, efficacy and safety of new pharmaceutical products, allowing developers to make timely decisions on the progression of drug candidates. Given their importance for de-risking development programs, it’s essential preclinical models are as translational to human pathology as...

Reducing attrition in drug discovery using improved candidate selection strategies and more translational models
Simone Braggio, 24 January 2018

Attrition in drug development has long been an issue for pharma.Despite passing industry trends and pipeline developments, it’s one that isn’t going away. To discuss solutions to this key challenge, experts from pharma and biotech met in Boston on December 4th 2017 for the concluding workshop in Aptuit’s conference series entitled Improving...

Three ways to manage risk in drug development
Ciriaco Maraschiello, 16 January 2018

Drug development can sometimes feel a little like a ski holiday in the Swiss Alps: an inherently costly and risky venture. Indeed, even a well-seasoned developer can soon find costs have snowballed, timelines have slipped, and a veritable mountain of resources has been invested in a program that has prematurely fallen by the wayside. However,...



Contact us


Business Development

T +44.(0)1235.86 15 61 T +1.732 329 2355 x3308